Table 2.
Clinical Characteristics of Patients With SARS-CoV-2 Undergoing EEG.
| Patient Characteristics | (N = 37 Patients) |
|---|---|
| Age in years, median (IQR) | 66.0 (59.5 - 76.3) |
| Gender | n/Total (%) |
| Female | 10/37 (27%) |
| Male | 27/37 (73%) |
| Preferred Language | n/Total (%) |
| English | 24/37 (65%) |
| Spanish | 8/37 (22%) |
| Haitian-Creole | 3/37 (8%) |
| Other | 2/37 (5%) |
| Race/Ethnicity | n/Total (%) |
| Hispanic/Latinx | 9/37 (24%) |
| Non-Hispanic Black | 12/37 (32%) |
| Non-Hispanic White | 14/37 (38%) |
| Non-Hispanic Asian | 2/37 (5%) |
| Respiratory Considerations | n/Total (%) |
| COVID-19 Findings on Chest Imaging | 32/37 (86%) |
| Intubated | 28/37 (76%) |
| Timing of Care | Median (IQR) |
| Days from Symptoms to Admission | 5.0 (0.0 – 9.0) |
| Days from Symptoms to EEG | 17.5 (8.5 – 27.5) |
| Length of Hospital Admission (days) | 26.5 (12.5 – 41.0) |
| Disposition | n/Total (%) |
| Death or Hospice | 10/37 (27%) |
| Discharge to Facility | 23/37 (62%) |
| Discharge to Home | 3/37 (8%) |
| Continued inpatient care | 1/37 (3%) |